Clinical Trials on Cocaine Use Disorder in New Zealand

Total 16291 results

Yale University

Terminated

Vitamin D and Cocaine Administration

Cocaine Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT) (Project 1)

Cocaine Use Disorder

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial

Cocaine Use Disorders

United States
UConn Health
National Institute on Drug Abuse (NIDA)

Completed

Extending Long-term Outcomes Through an Adaptive Aftercare Intervention

Contingency Management | Cocaine Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Recruiting

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Cocaine Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Treatment Outcome in CBT for Cocaine Use

Cocaine Use Disorder

United States
Soterix Medical
Icahn School of Medicine at Mount Sinai

Recruiting

tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

Cocaine Use Disorder | Cocaine Dependence

United States
Soterix Medical
Icahn School of Medicine at Mount Sinai

Unknown

tDCS to Reduce Craving in Cocaine Addiction

Cocaine Use Disorder | Cocaine Dependence

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Recruiting

Targeting Drug Memories With Methylphenidate

Substance Use Disorder | Cocaine Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Cocaine Use Disorder | Healthy Controls

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Recruiting

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CURB-2)

Cocaine Use Disorder

United States
Juul Labs, Inc.

Completed

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Juul Labs, Inc.

Completed

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Progesterone for Postpartum Cocaine Relapse

Cocaine Dependence | Cocaine Abuse

United States
Yale University

Terminated

Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction

Cocaine Dependent Subjects

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression

Depression | Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence (TACT)

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence (COST)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) (COST)

Cocaine Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Modafinil for Smoked Cocaine Self-Administration

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Therapeutic Cocaine Vaccine: Human Laboratory Study

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence (PET-CRA)

Cocaine Dependence

United States
Yale University

Terminated

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Cocaine Dependence

United States
Yale University

Completed

PET Imaging in Cocaine Self Administration

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues

Cocaine Dependence

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Multisite Controlled Trial of Cocaine Vaccine (TA-CD)

Cocaine Dependence

United States
Weill Medical College of Cornell University
National Institute on Drug Abuse (NIDA)

Recruiting

Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

CBT With Disulfiram and Contingency Management

Cocaine Abuse

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
New York State Psychiatric Institute

Completed

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Sequenced Behavioral and Medication Intervention for Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Cocaine-related Deficits

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (Vyvance)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Aripiprazole on Cocaine Craving and Self-Administration

Cocaine Abuse

United States
New York State Psychiatric Institute
Novel Cocaine Pharmacotherapies

Terminated

Effects of Vigabatrin on Cocaine Self-Administration

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Progesterone Treatment for Cocaine-dependent Women: A Pilot Study (PROG)

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Cocaine Dependence

United States
Yale University

Completed

Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Treatment for Cocaine Dependent Women

Cocaine Dependence

United States
Yale University

Completed

Modafinil, Sleep Architecture and Cocaine Relapse

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)

Cocaine Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

A Multi-Center Trial of Nepicastat for Cocaine Dependence

Cocaine Dependence

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Impulsivity and Stimulant Administration

Cocaine Dependence | Impulsivity

United States
Yale University

Completed

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

Cocaine Dependence | Opiate Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS

Healthy | Cocaine Dependence

United States

Clinical Trials on Cocaine Use Disorder in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations